High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skin
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 44 (6) , 1010-1024
- https://doi.org/10.1067/mjd.2001.112325
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- DermatomyositisJournal of the American Academy of Dermatology, 1998
- The value of methotrexate in dermatomyositisJournal of the American Academy of Dermatology, 1998
- Pyoderma gangrenosum: Classification and managementJournal of the American Academy of Dermatology, 1996
- Efficacy of human intravenous immune globulin in pyoderma gangrenosumJournal of the American Academy of Dermatology, 1995
- Epidermolysis bullosa acquisita: Efficacy of high-dose intravenous immunoglobulinsJournal of the American Academy of Dermatology, 1993
- Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki diseaseThe Journal of Pediatrics, 1992
- Effects of intravenous γ-globulin in pemphigusJournal of the American Academy of Dermatology, 1990
- Chlorambucil—An effective corticosteroid-sparing therapy for pyoderma gangrenosumJournal of the American Academy of Dermatology, 1989
- Asthma and selective immunoglobulin subclass deficiency: Improvement of asthma after immunoglobulin replacement therapyThe Journal of Pediatrics, 1988
- Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causesPublished by Elsevier ,1983